Press Releases
Date | Title | View |
---|---|---|
January 8, 2021 | Neoleukin Therapeutics Receives Clinical Hold Letter from U.S. FDA Related to CMC Assay Development for NL-201 | |
January 7, 2021 | Neoleukin Therapeutics to Present at J.P. Morgan Healthcare Conference |